Staley Capital Advisers Inc. Has $5.38 Million Stake in Option Care Health, Inc. $OPCH

Staley Capital Advisers Inc. lowered its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 11.1% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 200,000 shares of the company’s stock after selling 25,000 shares during the period. Staley Capital Advisers Inc. owned 0.13% of Option Care Health worth $5,384,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in the company. Fideuram Intesa Sanpaolo Private Banking S.P.A. bought a new position in Option Care Health during the 1st quarter worth $5,193,000. Janney Montgomery Scott LLC bought a new stake in shares of Option Care Health in the first quarter valued at about $248,000. Fort Washington Investment Advisors Inc. OH grew its stake in shares of Option Care Health by 2.9% in the first quarter. Fort Washington Investment Advisors Inc. OH now owns 1,479,728 shares of the company’s stock valued at $39,834,000 after acquiring an additional 42,317 shares in the last quarter. Pictet Asset Management Holding SA grew its stake in shares of Option Care Health by 6.4% in the first quarter. Pictet Asset Management Holding SA now owns 25,750 shares of the company’s stock valued at $693,000 after acquiring an additional 1,551 shares in the last quarter. Finally, Louisiana State Employees Retirement System bought a new position in Option Care Health during the first quarter worth about $1,238,000. 98.05% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Option Care Health news, CEO John Charles Rademacher bought 12,500 shares of Option Care Health stock in a transaction on Monday, May 4th. The shares were purchased at an average price of $21.18 per share, with a total value of $264,750.00. Following the acquisition, the chief executive officer owned 695,152 shares in the company, valued at $14,723,319.36. This trade represents a 1.83% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Harry M. Jansen Kraemer, Jr. bought 36,610 shares of Option Care Health stock in a transaction on Monday, May 4th. The stock was acquired at an average cost of $21.41 per share, for a total transaction of $783,820.10. Following the acquisition, the director owned 450,000 shares in the company, valued at approximately $9,634,500. This represents a 8.86% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired 73,264 shares of company stock worth $1,548,316 over the last three months. Insiders own 1.70% of the company’s stock.

Option Care Health Price Performance

Shares of NASDAQ:OPCH opened at $21.47 on Thursday. The firm has a 50 day moving average of $21.26 and a 200-day moving average of $27.99. The stock has a market capitalization of $3.37 billion, a PE ratio of 16.64, a PEG ratio of 1.20 and a beta of 0.65. The company has a current ratio of 1.64, a quick ratio of 1.07 and a debt-to-equity ratio of 0.85. Option Care Health, Inc. has a 12 month low of $18.01 and a 12 month high of $36.80.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings results on Thursday, April 30th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.03. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.39 billion. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The firm’s revenue for the quarter was up 1.3% on a year-over-year basis. During the same quarter last year, the business posted $0.40 EPS. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. On average, equities research analysts predict that Option Care Health, Inc. will post 1.64 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the stock. Stephens set a $30.00 price objective on shares of Option Care Health in a report on Friday, May 1st. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $26.00 target price on shares of Option Care Health in a report on Friday, May 1st. Weiss Ratings downgraded shares of Option Care Health from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. Barrington Research reduced their price target on Option Care Health from $42.00 to $32.00 and set an “outperform” rating on the stock in a research report on Friday, May 1st. Finally, Morgan Stanley set a $28.00 price objective on Option Care Health in a research note on Wednesday, May 6th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, Option Care Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $30.54.

Option Care Health Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.